4.7 Article

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 208, 期 12, 页码 2367-2374

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20110654

关键词

-

资金

  1. National Institute of Diabetes and Digestive and Kidney Diseases [5T32DK007296]
  2. National Heart, Lung and Blood Institute [2T32HL007317-31]
  3. Regione Lombardia Call per la ricerca indipendente
  4. NIH [R01 DE021255-01]
  5. National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology [A1067854]

向作者/读者索取更多资源

Plasmacytoid dendritic cells (pDCs) specialize in the secretion of type I interferons (IFN-I) and thus are considered critical mediators of antiviral responses. We recently reported that pDCs have a very early but limited and transient capacity to curtail viral infections. Additionally, pDC numbers are not sustained in human infections caused by Hepatitis B or C viruses (HBV and HCV) and HIV. Thus, the numbers and/or function of pDCs appear to be regulated during the course of viral infection. In this study, we show that splenic pDCs are reduced in vivo during several systemic viral infections and after administration of synthetic toll-like receptor ligands. We demonstrate that IFN-I, regardless of the source, contributes to this decline and mediates pDC death via the intrinsic apoptosis pathway. These findings demonstrate a feedback control mechanism by which IFN-I modulates pDC numbers, thus fine-tuning systemic IFN-I response to viruses. IFN-I-mediated control of pDCs may explain the loss of pDCs during human infections caused by HBV, HCV, or HIV and has important therapeutic implications for settings in which IFN-I is used to treat infections and autoimmune diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据